These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3829202)

  • 41. Synthesis of expected metabolites of benidipine hydrochloride.
    Muto K; Kuroda T; Kawato H; Nishikawa H; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1666-70. PubMed ID: 3219138
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and antihypertensive activities of 1,4-dihydropyridine-5-phosphonate derivatives. II.
    Morita I; Kunimoto K; Tsuda M; Tada S; Kise M; Kimura K
    Chem Pharm Bull (Tokyo); 1987 Oct; 35(10):4144-54. PubMed ID: 3435941
    [No Abstract]   [Full Text] [Related]  

  • 43. [Synthesis and comparative pharmacological studies of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylates with non-identical ester functions (author's transl)].
    Meyer H; Bossert F; Wehinger E; Stoepel K; Vater W
    Arzneimittelforschung; 1981; 31(3):407-9. PubMed ID: 7194663
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The influence of the ester function on the vasodilating activity of 1,4-dihydro-2,6-dimethyl-4-nitrophenyl-pyridine-3,5-dicarboxylates (author's transl)].
    Bossert F; Horstmann H; Meyer H; Vater W
    Arzneimittelforschung; 1979; 29(2):226-9. PubMed ID: 582135
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and antihypertensive activities of 1,4-dihydropyridine-5-phosphonate derivatives. I.
    Morita I; Tada S; Kunimoto K; Tsuda M; Kise M; Kimura K
    Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3898-904. PubMed ID: 3435985
    [No Abstract]   [Full Text] [Related]  

  • 46. New 1,4-dihydropyridine derivatives with potent and long-lasting hypotensive effect.
    Meguro K; Aizawa M; Sohda T; Kawamatsu Y; Nagaoka A
    Chem Pharm Bull (Tokyo); 1985 Sep; 33(9):3787-97. PubMed ID: 4092280
    [No Abstract]   [Full Text] [Related]  

  • 47. Hypotensive effects of dihydropyridine derivatives.
    Kamei C; Kurokawa K; Tasaka K
    Arzneimittelforschung; 1985; 35(9):1377-80. PubMed ID: 2935160
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The antihypertensive effect of orally administered nifedipine-loaded nanoparticles in spontaneously hypertensive rats.
    Kim YI; Fluckiger L; Hoffman M; Lartaud-Idjouadiene I; Atkinson J; Maincent P
    Br J Pharmacol; 1997 Feb; 120(3):399-404. PubMed ID: 9031742
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antihypertensive effect of the new dihydropyridine calcium antagonist (+-)-3-(benzylmethylamino)-2,2-dimethylpropyl methyl 4-(2-fluoro-5-nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedica rbo xylate hydrochloride in dogs.
    Okamiya Y; Kishimoto T; Sunakawa K; Aoki K; Tanabe H; Takeshita T; Naruchi T
    Arzneimittelforschung; 1992 Apr; 42(4):513-8. PubMed ID: 1642675
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Studies on nilvadipine. I. Synthesis and structure-activity relationships of 1,4-dihydropyridines containing novel substituents at the 2-position.
    Satoh Y; Ichihashi M; Okumura K
    Chem Pharm Bull (Tokyo); 1991 Dec; 39(12):3189-201. PubMed ID: 1814611
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of effects of a new dihydropyridine, Bay K 8644, and nifedipine on spontaneous mechanical activity in rat portal vein.
    Mikkelsen E
    Br J Pharmacol; 1985 Jun; 85(2):383-5. PubMed ID: 2411322
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiovascular activities of the new potent and long-lasting antihypertensive calcium entry blocker (+-)-3-ethyl,5-methyl,2- ([2-(formylamino)-ethyl]- thiomethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicar box ylate.
    Germini M; Passoni A; Casciarri I; Bosetti P; Piazzoni L; Cazzulani P; Gandolfi CA; Tofanetti O; Ceserani R
    Arzneimittelforschung; 1992 Jan; 42(1):1-8. PubMed ID: 1586373
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Central control of the baroreflex response to phenylephrine by dihydropyridines in the anesthetized rat].
    Lacolley P; Laurent S; Tsoucaris-Kupfer D; Legrand M; Brisac AM; Schmitt H
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():119-23. PubMed ID: 2461181
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of a novel calcium antagonist, S-(+)-methyl-4,7-dihydro-3-isobutyl-6- methyl-4-(3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate (S-312-d), on ischemic amino acid release and neuronal injury in stroke-prone spontaneously hypertensive rats.
    Gemba T; Ninomiya M; Matsunaga K; Ueda M
    J Pharmacol Exp Ther; 1993 Apr; 265(1):463-7. PubMed ID: 8474028
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuroprotective effects of a dihydropyridine derivative, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarbox ylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester (CV-159), on rat ischemic brain injury.
    Miyazaki H; Tanaka S; Fujii Y; Shimizu K; Nagashima K; Kamibayashi M; Uehara T; Okuma Y; Nomura Y
    Life Sci; 1999; 64(10):869-78. PubMed ID: 10096437
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis of a new class of 1,4-dihydropyridines having a hydroxamic ester group in position 3 with a potential calcium antagonistic activity.
    Inglesi M; Nicola M; Magnetti S
    Farmaco; 1990 Dec; 45(12):1327-40. PubMed ID: 2090142
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of turkey gizzard myosin light chain. Kinase activity by dihydropyridine calcium antagonists.
    Movsesian MA; Swain AL; Adelstein RS
    Biochem Pharmacol; 1984 Dec; 33(23):3759-64. PubMed ID: 6548915
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dihydropyridines alter adenosine sensitivity in the rat hippocampal slice.
    Bartrup JT; Stone TW
    Br J Pharmacol; 1990 Sep; 101(1):97-102. PubMed ID: 1704273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preparation and properties of ryodipine, an effective antihypertensive agent.
    Kastron VV; Dubur GJ; Shatz VD; Yagupolsky LM
    Arzneimittelforschung; 1985; 35(4):668-72. PubMed ID: 4015732
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Binding of a calcium antagonist, [3H]nitrendipine, to high affinity sites in bovine aortic smooth muscle and canine cardiac membranes.
    Williams LT; Tremble P
    J Clin Invest; 1982 Jul; 70(1):209-12. PubMed ID: 6282938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.